27 11, 2016 Adriana Romiti et al., The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs Diatech Pharmacogenetics2017-08-07T10:02:57+02:00 Leggi di più
